Ambrx Funding & Investors
Los Angeles, CA
Ambrx, Inc. operates as a biopharmaceutical company. The Company develops therapeutics such as long acting proteins, bi-specifics, and antibody drug conjugates. Ambrx operates in worldwide.
ambrx.comTotal Amount Raised: $500,948,992
Ambrx Funding Rounds
Post Ipo Equity
$75,000,000
Post Ipo Equity
$78,000,000
IPO
Unknown
Private Equity
$200,000,000
Private Equity Investors
Adage Capital ManagementBlackRockInvusFidelity InvestmentsHBM Healthcare InvestmentsCormorant Asset ManagementSuvretta Capital ManagementSeries Unknown
$45,000,000
Series Unknown Investors
Apricot CapitalNortheast SecuritiesSINOPHARMHOPU InvestmentEverbrightHumanwell Healthcare (Group) Co.Shanghai Fosun Pharmaceutical (Group) Co.Series D
$10,000,000
Series D Investors
Versant VenturesMaverick VenturesAravisTavistock Group5am VenturesCMEA CapitalM VenturesSeries C
$52,000,000
Series C Investors
Apposite CapitalTavistock GroupMaverick Ventures5am VenturesVersant VenturesAravisCMEA CapitalRoche Venture FundSeries B
$5,000,000
Series B Investors
Tavistock GroupVersant Ventures5am VenturesSeries A
$23,449,000
Series A Investors
Maverick VenturesTavistock GroupVersant Ventures5am VenturesSeries A
$12,500,000
Series A Investors
Tavistock Group5am Ventures
Funding info provided by Diffbot.